Earnings Feed
Start Free
Home/Filings/4/0001140361-11-001841
4//SEC Filing

SIGMA TAU FINANZIARIA SPA 4

Accession 0001140361-11-001841

CIK 0000707511other
View on SEC.govCompany Profile

Filed

Jan 6, 7:00 PM ET

Accepted

Jan 7, 12:54 PM ET

Size

25.6 KB

Accession

0001140361-11-001841

Insider Transaction Report

Form 4
Period: 2011-01-05
REGENERX BIOPHARMACEUTICALS INCRGRX.OB
SIGMA TAU FINANZIARIA SPA
10% Owner
Transactions
  • Purchase

    Common Stock

    2011-01-05$0.27/sh+925,926$250,000→ 12,937,111 total(indirect: Indirect)
  • Other

    Common Stock Warrants (right to buy)

    2011-01-05+1→ 1 total(indirect: Indirect)
    Exercise: $0.38From: 2011-07-07Exp: 2016-01-07→ Common Stock (370,370 underlying)
  • Other

    Common Stock Warrants (right to buy)

    2011-01-05−1→ 0 total(indirect: Indirect)
    Exercise: $4.06Exp: 2011-03-16→ Common Stock (256,148 underlying)
  • Other

    Common Stock Warrants (right to buy)

    2011-01-05+1→ 1 total(indirect: Indirect)
    Exercise: $0.38Exp: 2011-12-31→ Common Stock (256,148 underlying)
  • Other

    Common Stock Warrants (right to buy)

    2011-01-05−1→ 0 total(indirect: Indirect)
    Exercise: $2.75Exp: 2011-12-21→ Common Stock (333,333 underlying)
  • Other

    Common Stock Warrants (right to buy)

    2011-01-05+1→ 2 total(indirect: Indirect)
    Exercise: $0.38Exp: 2011-12-31→ Common Stock (333,333 underlying)
Holdings

  • Common Stock

    984,615
DEFIANTE FARMACEUTICA LDA
10% Owner
Transactions
  • Purchase

    Common Stock

    2011-01-05$0.27/sh+925,926$250,000→ 12,937,111 total(indirect: Indirect)
  • Other

    Common Stock Warrants (right to buy)

    2011-01-05+1→ 1 total(indirect: Indirect)
    Exercise: $0.38From: 2011-07-07Exp: 2016-01-07→ Common Stock (370,370 underlying)
  • Other

    Common Stock Warrants (right to buy)

    2011-01-05−1→ 0 total(indirect: Indirect)
    Exercise: $4.06Exp: 2011-03-16→ Common Stock (256,148 underlying)
  • Other

    Common Stock Warrants (right to buy)

    2011-01-05+1→ 1 total(indirect: Indirect)
    Exercise: $0.38Exp: 2011-12-31→ Common Stock (256,148 underlying)
  • Other

    Common Stock Warrants (right to buy)

    2011-01-05−1→ 0 total(indirect: Indirect)
    Exercise: $2.75Exp: 2011-12-21→ Common Stock (333,333 underlying)
  • Other

    Common Stock Warrants (right to buy)

    2011-01-05+1→ 2 total(indirect: Indirect)
    Exercise: $0.38Exp: 2011-12-31→ Common Stock (333,333 underlying)
Holdings

  • Common Stock

    984,615
Footnotes (4)
  • [F1]Securities directly owned by Defiante Farmaceutica S.A. ("Defiante"). Defiante is 58% directly owned by Sigma Tau Finanziaria S.p.A. ("Sigma Tau") and 42% directly owned by Sigma Tau's wholly-owned subsidiary, Sigma Tau International S.A.
  • [F2]The Warrant was issued by the Issuer to Defiante in consideration of Defiante's purchase of Common Stock.
  • [F3]The two reported transactions involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the issuance of a replacement warrant. The warrant became exercisable on September 16, 2006.
  • [F4]The two reported transactions involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the issuance of a replacement warrant. The warrant became exercisable on December 21, 2006.

Documents

2 files

Issuer

REGENERX BIOPHARMACEUTICALS INC

CIK 0000707511

→
Entity typeother

Related Parties

1
  • filerCIK 0001092601

Filing Metadata

Form type
4
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 12:54 PM ET
Size
25.6 KB
View on SEC.gov